Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J; ARAMIS Study Group. Manolis AJ, et al. Among authors: koster j. J Hypertens. 2004 May;22(5):1033-7. doi: 10.1097/00004872-200405000-00027. J Hypertens. 2004. PMID: 15097245 Clinical Trial.
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Vogt L, Navis G, Köster J, Manolis AJ, Reid JL, de Zeeuw D; Angiotensin II Receptor Antagonist Telmisartan Micardis in Isolated Systolic Hypertension (ARAMIS) Study Group. Vogt L, et al. Among authors: koster j. J Hypertens. 2005 Nov;23(11):2055-61. doi: 10.1097/01.hjh.0000186829.56372.04. J Hypertens. 2005. PMID: 16208149 Clinical Trial.
872 results